Triple negative breast cancer metastasis is hindered by a peptide antagonist of F11R/JAM‑A protein

BACKGROUND: The F11R/JAM-A cell adhesion protein was examined as the therapeutic target in triple negative breast cancer (TNBC) with the use of the peptide antagonist to F11R/JAM-A, that previously inhibited the early stages of breast cancer metastasis in vitro. METHODS: The online in silico analysi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bednarek, Radosław, Wojkowska, Dagmara W., Braun, Marcin, Watala, Cezary, Salifu, Moro O., Swiatkowska, Maria, Babinska, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416405/
https://www.ncbi.nlm.nih.gov/pubmed/37563645
http://dx.doi.org/10.1186/s12935-023-03023-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416405/
https://www.ncbi.nlm.nih.gov/pubmed/37563645
http://dx.doi.org/10.1186/s12935-023-03023-4

Ejemplares similares